MAPK9 and Alzheimer disease: All 11 candidate hub genes were expressed at different levels in AD and normal samples of the GSE132903 dataset, with APP, MAPK1, MAPK9, and MAPT expression levels higher in control samples and the rest higher in AD samples (Fig. 12).